Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Nov;27(9):885-90.
doi: 10.3109/07357900903275142.

Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer

Affiliations
Review

Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer

Nicole M Kuderer et al. Cancer Invest. 2009 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot of the positive predictive value of gene expression profile signatures ± 95% CLs in ESBC estimated by the Mantel-Haenszel method for each study. The weighted combined positive predictive value ± 95% CLs based on a random effects model is shown at the bottom.
Figure 2
Figure 2
Forest plot of the negative predictive value of gene expression profile signatures ±95% CLs in ESBC estimated by the Mantel—Haenszel method for each study. The weighted combined negative predictive value ±95% CLs based on a random effects model is shown at the bottom.
Figure 3
Figure 3
Graph of the diagnostic odds ratio and the number of genes in the assay signature from each study of patients with early-stage breast cancer. The filled line is based on linear regression on the mean ±95% CLs.

Similar articles

Cited by

References

    1. Altman DG, Lyman GH. Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat. 1998;52:289–303. - PubMed
    1. Laird MM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care. 1990;6:5–30. - PubMed
    1. Higgins JP, Thompson SG, Deeks JJ, Altman D. Measuring inconsistency in meta-analyses. Brit Med J. 2003;327:557–560. - PMC - PubMed
    1. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Contr Clin Trials. 1986;7:177–188. - PubMed
    1. van’t Veer LJ, Dai H, van De Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–536. - PubMed